These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 11169951

  • 1. Regulation of urokinase plasminogen activator/plasmin-mediated invasion of melanoma cells by the integrin vitronectin receptor alphaVbeta3.
    Khatib AM, Nip J, Fallavollita L, Lehmann M, Jensen G, Brodt P.
    Int J Cancer; 2001 Feb 01; 91(3):300-8. PubMed ID: 11169951
    [Abstract] [Full Text] [Related]

  • 2. Coordinated expression of the vitronectin receptor and the urokinase-type plasminogen activator receptor in metastatic melanoma cells.
    Nip J, Rabbani SA, Shibata HR, Brodt P.
    J Clin Invest; 1995 May 01; 95(5):2096-103. PubMed ID: 7537755
    [Abstract] [Full Text] [Related]

  • 3. Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness.
    Bryan L, Paugh BS, Kapitonov D, Wilczynska KM, Alvarez SM, Singh SK, Milstien S, Spiegel S, Kordula T.
    Mol Cancer Res; 2008 Sep 01; 6(9):1469-77. PubMed ID: 18819934
    [Abstract] [Full Text] [Related]

  • 4. Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness.
    Holst-Hansen C, Johannessen B, Høyer-Hansen G, Rømer J, Ellis V, Brünner N.
    Clin Exp Metastasis; 1996 May 01; 14(3):297-307. PubMed ID: 8674284
    [Abstract] [Full Text] [Related]

  • 5. Requirement of receptor-bound urokinase-type plasminogen activator for integrin alphavbeta5-directed cell migration.
    Yebra M, Parry GC, Strömblad S, Mackman N, Rosenberg S, Mueller BM, Cheresh DA.
    J Biol Chem; 1996 Nov 15; 271(46):29393-9. PubMed ID: 8910604
    [Abstract] [Full Text] [Related]

  • 6. Melanoma cell migration on vitronectin: regulation by components of the plasminogen activation system.
    Stahl A, Mueller BM.
    Int J Cancer; 1997 Mar 28; 71(1):116-22. PubMed ID: 9096674
    [Abstract] [Full Text] [Related]

  • 7. CD44 stimulation by fragmented hyaluronic acid induces upregulation of urokinase-type plasminogen activator and its receptor and subsequently facilitates invasion of human chondrosarcoma cells.
    Kobayashi H, Suzuki M, Kanayama N, Nishida T, Takigawa M, Terao T.
    Int J Cancer; 2002 Dec 01; 102(4):379-89. PubMed ID: 12402308
    [Abstract] [Full Text] [Related]

  • 8. Role of urokinase plasminogen activator receptor in thrombospondin 1-mediated tumor cell invasion.
    Albo D, Berger DH, Rothman VL, Tuszynski GP.
    J Surg Res; 1999 Apr 01; 82(2):331-8. PubMed ID: 10090848
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.
    Iwamoto J, Mizokami Y, Takahashi K, Nakajima K, Ohtsubo T, Miura S, Narasaka T, Takeyama H, Omata T, Shimokobe K, Ito M, Takehara H, Matsuoka T.
    Scand J Gastroenterol; 2005 Jul 01; 40(7):783-93. PubMed ID: 16109653
    [Abstract] [Full Text] [Related]

  • 13. Invasion and metastasis of hepatocellular carcinoma in relation to urokinase-type plasminogen activator, its receptor and inhibitor.
    Zheng Q, Tang ZY, Xue Q, Shi DR, Song HY, Tang HB.
    J Cancer Res Clin Oncol; 2000 Nov 01; 126(11):641-6. PubMed ID: 11079728
    [Abstract] [Full Text] [Related]

  • 14. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R, Schaaf A.
    Int J Oncol; 2009 Jan 01; 34(1):15-23. PubMed ID: 19082473
    [Abstract] [Full Text] [Related]

  • 15. Elevated urokinase-specific surface receptor expression is maintained through its interaction with urokinase plasminogen activator.
    Mahanivong C, Yu J, Huang S.
    Mol Carcinog; 2007 Mar 01; 46(3):165-75. PubMed ID: 17186542
    [Abstract] [Full Text] [Related]

  • 16. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
    Kobayashi H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug 01; 48(8):623-32. PubMed ID: 8808830
    [Abstract] [Full Text] [Related]

  • 17. Up-regulation of urokinase-type plasminogen activator and its receptor correlates with enhanced invasion activity of human glioma cells mediated by transforming growth factor-alpha or basic fibroblast growth factor.
    Mori T, Abe T, Wakabayashi Y, Hikawa T, Matsuo K, Yamada Y, Kuwano M, Hori S.
    J Neurooncol; 2000 Aug 01; 46(2):115-23. PubMed ID: 10894364
    [Abstract] [Full Text] [Related]

  • 18. Role of urokinase plasminogen activator and its receptor in metastasis and invasion of neuroblastoma.
    Li P, Gao Y, Ji Z, Zhang X, Xu Q, Li G, Guo Z, Zheng B, Guo X.
    J Pediatr Surg; 2004 Oct 01; 39(10):1512-9. PubMed ID: 15486896
    [Abstract] [Full Text] [Related]

  • 19. Co-expression of urokinase, urokinase receptor and PAI-1 is necessary for optimum invasiveness of cultured lung cancer cells.
    Liu G, Shuman MA, Cohen RL.
    Int J Cancer; 1995 Feb 08; 60(4):501-6. PubMed ID: 7829264
    [Abstract] [Full Text] [Related]

  • 20. Oestradiol regulation of the components of the plasminogen-plasmin system in MDA-MB-231 human breast cancer cells stably expressing the oestrogen receptor.
    Levenson AS, Kwaan HC, Svoboda KM, Weiss IM, Sakurai S, Jordan VC.
    Br J Cancer; 1998 Jul 08; 78(1):88-95. PubMed ID: 9662256
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.